nodes	percent_of_prediction	percent_of_DWPC	metapath
Milnacipran—Shock—Pamidronate—osteoporosis	0.00112	0.00112	CcSEcCtD
Milnacipran—Loss of consciousness—Zoledronate—osteoporosis	0.00112	0.00112	CcSEcCtD
Milnacipran—Hypersensitivity—Estropipate—osteoporosis	0.00112	0.00112	CcSEcCtD
Milnacipran—Nervous system disorder—Pamidronate—osteoporosis	0.00112	0.00112	CcSEcCtD
Milnacipran—Thrombocytopenia—Pamidronate—osteoporosis	0.00112	0.00112	CcSEcCtD
Milnacipran—Urinary tract disorder—Estradiol—osteoporosis	0.00112	0.00112	CcSEcCtD
Milnacipran—Vomiting—Etidronic acid—osteoporosis	0.00111	0.00111	CcSEcCtD
Milnacipran—Oedema peripheral—Estradiol—osteoporosis	0.00111	0.00111	CcSEcCtD
Milnacipran—Tachycardia—Pamidronate—osteoporosis	0.00111	0.00111	CcSEcCtD
Milnacipran—Connective tissue disorder—Estradiol—osteoporosis	0.00111	0.00111	CcSEcCtD
Milnacipran—Urethral disorder—Estradiol—osteoporosis	0.00111	0.00111	CcSEcCtD
Milnacipran—Rash—Etidronic acid—osteoporosis	0.00111	0.00111	CcSEcCtD
Milnacipran—Convulsion—Zoledronate—osteoporosis	0.00111	0.00111	CcSEcCtD
Milnacipran—Dermatitis—Etidronic acid—osteoporosis	0.0011	0.0011	CcSEcCtD
Milnacipran—Hyperhidrosis—Pamidronate—osteoporosis	0.0011	0.0011	CcSEcCtD
Milnacipran—Syncope—Conjugated Estrogens—osteoporosis	0.0011	0.0011	CcSEcCtD
Milnacipran—Hypertension—Zoledronate—osteoporosis	0.0011	0.0011	CcSEcCtD
Milnacipran—Hypersensitivity—Alendronate—osteoporosis	0.0011	0.0011	CcSEcCtD
Milnacipran—Headache—Etidronic acid—osteoporosis	0.0011	0.0011	CcSEcCtD
Milnacipran—Asthenia—Estropipate—osteoporosis	0.00109	0.00109	CcSEcCtD
Milnacipran—Anorexia—Pamidronate—osteoporosis	0.00109	0.00109	CcSEcCtD
Milnacipran—Chest pain—Zoledronate—osteoporosis	0.00109	0.00109	CcSEcCtD
Milnacipran—Palpitations—Conjugated Estrogens—osteoporosis	0.00109	0.00109	CcSEcCtD
Milnacipran—Insomnia—Risedronate—osteoporosis	0.00108	0.00108	CcSEcCtD
Milnacipran—Anxiety—Zoledronate—osteoporosis	0.00108	0.00108	CcSEcCtD
Milnacipran—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00108	0.00108	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00108	0.00108	CcSEcCtD
Milnacipran—Paraesthesia—Risedronate—osteoporosis	0.00108	0.00108	CcSEcCtD
Milnacipran—Pruritus—Estropipate—osteoporosis	0.00107	0.00107	CcSEcCtD
Milnacipran—Asthenia—Alendronate—osteoporosis	0.00107	0.00107	CcSEcCtD
Milnacipran—Hypersensitivity—Ibandronate—osteoporosis	0.00107	0.00107	CcSEcCtD
Milnacipran—Dyspnoea—Risedronate—osteoporosis	0.00107	0.00107	CcSEcCtD
Milnacipran—Erythema multiforme—Estradiol—osteoporosis	0.00107	0.00107	CcSEcCtD
Milnacipran—Hypotension—Pamidronate—osteoporosis	0.00106	0.00106	CcSEcCtD
Milnacipran—Convulsion—Conjugated Estrogens—osteoporosis	0.00106	0.00106	CcSEcCtD
Milnacipran—Dry mouth—Zoledronate—osteoporosis	0.00106	0.00106	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00106	0.00106	CcSEcCtD
Milnacipran—Fatigue—Ethinyl Estradiol—osteoporosis	0.00106	0.00106	CcSEcCtD
Milnacipran—Pruritus—Alendronate—osteoporosis	0.00106	0.00106	CcSEcCtD
Milnacipran—Dyspepsia—Risedronate—osteoporosis	0.00106	0.00106	CcSEcCtD
Milnacipran—Eye disorder—Estradiol—osteoporosis	0.00106	0.00106	CcSEcCtD
Milnacipran—Constipation—Ethinyl Estradiol—osteoporosis	0.00105	0.00105	CcSEcCtD
Milnacipran—Hypersensitivity—Calcitriol—osteoporosis	0.00105	0.00105	CcSEcCtD
Milnacipran—Cardiac disorder—Estradiol—osteoporosis	0.00105	0.00105	CcSEcCtD
Milnacipran—Flushing—Estradiol—osteoporosis	0.00105	0.00105	CcSEcCtD
Milnacipran—Chest pain—Conjugated Estrogens—osteoporosis	0.00105	0.00105	CcSEcCtD
Milnacipran—Asthenia—Ibandronate—osteoporosis	0.00104	0.00104	CcSEcCtD
Milnacipran—Anxiety—Conjugated Estrogens—osteoporosis	0.00104	0.00104	CcSEcCtD
Milnacipran—Nausea—Etidronic acid—osteoporosis	0.00104	0.00104	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00104	0.00104	CcSEcCtD
Milnacipran—Diarrhoea—Estropipate—osteoporosis	0.00104	0.00104	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Risedronate—osteoporosis	0.00103	0.00103	CcSEcCtD
Milnacipran—Infection—Zoledronate—osteoporosis	0.00103	0.00103	CcSEcCtD
Milnacipran—Fatigue—Risedronate—osteoporosis	0.00103	0.00103	CcSEcCtD
Milnacipran—Insomnia—Pamidronate—osteoporosis	0.00103	0.00103	CcSEcCtD
Milnacipran—Pruritus—Ibandronate—osteoporosis	0.00103	0.00103	CcSEcCtD
Milnacipran—Constipation—Risedronate—osteoporosis	0.00103	0.00103	CcSEcCtD
Milnacipran—Angiopathy—Estradiol—osteoporosis	0.00102	0.00102	CcSEcCtD
Milnacipran—Shock—Zoledronate—osteoporosis	0.00102	0.00102	CcSEcCtD
Milnacipran—Paraesthesia—Pamidronate—osteoporosis	0.00102	0.00102	CcSEcCtD
Milnacipran—Diarrhoea—Alendronate—osteoporosis	0.00102	0.00102	CcSEcCtD
Milnacipran—Asthenia—Calcitriol—osteoporosis	0.00102	0.00102	CcSEcCtD
Milnacipran—Nervous system disorder—Zoledronate—osteoporosis	0.00102	0.00102	CcSEcCtD
Milnacipran—Thrombocytopenia—Zoledronate—osteoporosis	0.00102	0.00102	CcSEcCtD
Milnacipran—Mediastinal disorder—Estradiol—osteoporosis	0.00102	0.00102	CcSEcCtD
Milnacipran—Dyspnoea—Pamidronate—osteoporosis	0.00102	0.00102	CcSEcCtD
Milnacipran—Tachycardia—Zoledronate—osteoporosis	0.00102	0.00102	CcSEcCtD
Milnacipran—Chills—Estradiol—osteoporosis	0.00101	0.00101	CcSEcCtD
Milnacipran—Somnolence—Pamidronate—osteoporosis	0.00101	0.00101	CcSEcCtD
Milnacipran—Skin disorder—Zoledronate—osteoporosis	0.00101	0.00101	CcSEcCtD
Milnacipran—Pruritus—Calcitriol—osteoporosis	0.00101	0.00101	CcSEcCtD
Milnacipran—Hyperhidrosis—Zoledronate—osteoporosis	0.00101	0.00101	CcSEcCtD
Milnacipran—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00101	0.00101	CcSEcCtD
Milnacipran—Diarrhoea—Raloxifene—osteoporosis	0.00101	0.00101	CcSEcCtD
Milnacipran—Dyspepsia—Pamidronate—osteoporosis	0.001	0.001	CcSEcCtD
Milnacipran—Dizziness—Estropipate—osteoporosis	0.001	0.001	CcSEcCtD
Milnacipran—Infection—Conjugated Estrogens—osteoporosis	0.000996	0.000996	CcSEcCtD
Milnacipran—Diarrhoea—Ibandronate—osteoporosis	0.000995	0.000995	CcSEcCtD
Milnacipran—Anorexia—Zoledronate—osteoporosis	0.000992	0.000992	CcSEcCtD
Milnacipran—Decreased appetite—Pamidronate—osteoporosis	0.000991	0.000991	CcSEcCtD
Milnacipran—Mental disorder—Estradiol—osteoporosis	0.000989	0.000989	CcSEcCtD
Milnacipran—Dizziness—Alendronate—osteoporosis	0.000988	0.000988	CcSEcCtD
Milnacipran—Shock—Conjugated Estrogens—osteoporosis	0.000986	0.000986	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000984	0.000984	CcSEcCtD
Milnacipran—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000983	0.000983	CcSEcCtD
Milnacipran—Malnutrition—Estradiol—osteoporosis	0.000983	0.000983	CcSEcCtD
Milnacipran—Fatigue—Pamidronate—osteoporosis	0.000982	0.000982	CcSEcCtD
Milnacipran—Gastrointestinal pain—Risedronate—osteoporosis	0.00098	0.00098	CcSEcCtD
Milnacipran—Tachycardia—Conjugated Estrogens—osteoporosis	0.000978	0.000978	CcSEcCtD
Milnacipran—Urticaria—Ethinyl Estradiol—osteoporosis	0.000977	0.000977	CcSEcCtD
Milnacipran—Constipation—Pamidronate—osteoporosis	0.000975	0.000975	CcSEcCtD
Milnacipran—Diarrhoea—Calcitriol—osteoporosis	0.000974	0.000974	CcSEcCtD
Milnacipran—Skin disorder—Conjugated Estrogens—osteoporosis	0.000974	0.000974	CcSEcCtD
Milnacipran—Hypotension—Zoledronate—osteoporosis	0.000973	0.000973	CcSEcCtD
Milnacipran—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000972	0.000972	CcSEcCtD
Milnacipran—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000972	0.000972	CcSEcCtD
Milnacipran—Dizziness—Raloxifene—osteoporosis	0.000972	0.000972	CcSEcCtD
Milnacipran—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000969	0.000969	CcSEcCtD
Milnacipran—Flatulence—Estradiol—osteoporosis	0.000969	0.000969	CcSEcCtD
Milnacipran—Tension—Estradiol—osteoporosis	0.000965	0.000965	CcSEcCtD
Milnacipran—Vomiting—Estropipate—osteoporosis	0.000964	0.000964	CcSEcCtD
Milnacipran—Dysgeusia—Estradiol—osteoporosis	0.000963	0.000963	CcSEcCtD
Milnacipran—Dizziness—Ibandronate—osteoporosis	0.000962	0.000962	CcSEcCtD
Milnacipran—Rash—Estropipate—osteoporosis	0.000956	0.000956	CcSEcCtD
Milnacipran—Dermatitis—Estropipate—osteoporosis	0.000956	0.000956	CcSEcCtD
Milnacipran—Anorexia—Conjugated Estrogens—osteoporosis	0.000955	0.000955	CcSEcCtD
Milnacipran—Urticaria—Risedronate—osteoporosis	0.000952	0.000952	CcSEcCtD
Milnacipran—Headache—Estropipate—osteoporosis	0.00095	0.00095	CcSEcCtD
Milnacipran—Vomiting—Alendronate—osteoporosis	0.00095	0.00095	CcSEcCtD
Milnacipran—Abdominal pain—Risedronate—osteoporosis	0.000948	0.000948	CcSEcCtD
Milnacipran—Body temperature increased—Risedronate—osteoporosis	0.000948	0.000948	CcSEcCtD
Milnacipran—Rash—Alendronate—osteoporosis	0.000942	0.000942	CcSEcCtD
Milnacipran—Insomnia—Zoledronate—osteoporosis	0.000941	0.000941	CcSEcCtD
Milnacipran—Dermatitis—Alendronate—osteoporosis	0.000941	0.000941	CcSEcCtD
Milnacipran—Hypotension—Conjugated Estrogens—osteoporosis	0.000937	0.000937	CcSEcCtD
Milnacipran—Headache—Alendronate—osteoporosis	0.000936	0.000936	CcSEcCtD
Milnacipran—Paraesthesia—Zoledronate—osteoporosis	0.000935	0.000935	CcSEcCtD
Milnacipran—Vomiting—Raloxifene—osteoporosis	0.000934	0.000934	CcSEcCtD
Milnacipran—Gastrointestinal pain—Pamidronate—osteoporosis	0.000932	0.000932	CcSEcCtD
Milnacipran—Dyspnoea—Zoledronate—osteoporosis	0.000928	0.000928	CcSEcCtD
Milnacipran—Rash—Raloxifene—osteoporosis	0.000926	0.000926	CcSEcCtD
Milnacipran—Dermatitis—Raloxifene—osteoporosis	0.000926	0.000926	CcSEcCtD
Milnacipran—Somnolence—Zoledronate—osteoporosis	0.000925	0.000925	CcSEcCtD
Milnacipran—Vomiting—Ibandronate—osteoporosis	0.000925	0.000925	CcSEcCtD
Milnacipran—Tremor—Estradiol—osteoporosis	0.000921	0.000921	CcSEcCtD
Milnacipran—Headache—Raloxifene—osteoporosis	0.00092	0.00092	CcSEcCtD
Milnacipran—Rash—Ibandronate—osteoporosis	0.000917	0.000917	CcSEcCtD
Milnacipran—Dermatitis—Ibandronate—osteoporosis	0.000916	0.000916	CcSEcCtD
Milnacipran—Dyspepsia—Zoledronate—osteoporosis	0.000916	0.000916	CcSEcCtD
Milnacipran—Headache—Ibandronate—osteoporosis	0.000911	0.000911	CcSEcCtD
Milnacipran—Insomnia—Conjugated Estrogens—osteoporosis	0.000907	0.000907	CcSEcCtD
Milnacipran—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000906	0.000906	CcSEcCtD
Milnacipran—Vomiting—Calcitriol—osteoporosis	0.000905	0.000905	CcSEcCtD
Milnacipran—Decreased appetite—Zoledronate—osteoporosis	0.000905	0.000905	CcSEcCtD
Milnacipran—Agitation—Estradiol—osteoporosis	0.000903	0.000903	CcSEcCtD
Milnacipran—Nausea—Estropipate—osteoporosis	0.000901	0.000901	CcSEcCtD
Milnacipran—Body temperature increased—Pamidronate—osteoporosis	0.000901	0.000901	CcSEcCtD
Milnacipran—Abdominal pain—Pamidronate—osteoporosis	0.000901	0.000901	CcSEcCtD
Milnacipran—Paraesthesia—Conjugated Estrogens—osteoporosis	0.0009	0.0009	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000899	0.000899	CcSEcCtD
Milnacipran—Rash—Calcitriol—osteoporosis	0.000898	0.000898	CcSEcCtD
Milnacipran—Fatigue—Zoledronate—osteoporosis	0.000897	0.000897	CcSEcCtD
Milnacipran—Dermatitis—Calcitriol—osteoporosis	0.000897	0.000897	CcSEcCtD
Milnacipran—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000894	0.000894	CcSEcCtD
Milnacipran—Headache—Calcitriol—osteoporosis	0.000892	0.000892	CcSEcCtD
Milnacipran—Somnolence—Conjugated Estrogens—osteoporosis	0.000891	0.000891	CcSEcCtD
Milnacipran—Constipation—Zoledronate—osteoporosis	0.00089	0.00089	CcSEcCtD
Milnacipran—Nausea—Alendronate—osteoporosis	0.000887	0.000887	CcSEcCtD
Milnacipran—Hypersensitivity—Risedronate—osteoporosis	0.000883	0.000883	CcSEcCtD
Milnacipran—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000882	0.000882	CcSEcCtD
Milnacipran—Asthenia—Ethinyl Estradiol—osteoporosis	0.000882	0.000882	CcSEcCtD
Milnacipran—Syncope—Estradiol—osteoporosis	0.000881	0.000881	CcSEcCtD
Milnacipran—Nausea—Raloxifene—osteoporosis	0.000873	0.000873	CcSEcCtD
Milnacipran—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000871	0.000871	CcSEcCtD
Milnacipran—Pruritus—Ethinyl Estradiol—osteoporosis	0.00087	0.00087	CcSEcCtD
Milnacipran—Palpitations—Estradiol—osteoporosis	0.000869	0.000869	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000865	0.000865	CcSEcCtD
Milnacipran—Fatigue—Conjugated Estrogens—osteoporosis	0.000864	0.000864	CcSEcCtD
Milnacipran—Nausea—Ibandronate—osteoporosis	0.000864	0.000864	CcSEcCtD
Milnacipran—Loss of consciousness—Estradiol—osteoporosis	0.000864	0.000864	CcSEcCtD
Milnacipran—Asthenia—Risedronate—osteoporosis	0.00086	0.00086	CcSEcCtD
Milnacipran—Constipation—Conjugated Estrogens—osteoporosis	0.000857	0.000857	CcSEcCtD
Milnacipran—Gastrointestinal pain—Zoledronate—osteoporosis	0.000851	0.000851	CcSEcCtD
Milnacipran—Hypertension—Estradiol—osteoporosis	0.000849	0.000849	CcSEcCtD
Milnacipran—Pruritus—Risedronate—osteoporosis	0.000848	0.000848	CcSEcCtD
Milnacipran—Nausea—Calcitriol—osteoporosis	0.000846	0.000846	CcSEcCtD
Milnacipran—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000841	0.000841	CcSEcCtD
Milnacipran—Hypersensitivity—Pamidronate—osteoporosis	0.00084	0.00084	CcSEcCtD
Milnacipran—Chest pain—Estradiol—osteoporosis	0.000837	0.000837	CcSEcCtD
Milnacipran—Anxiety—Estradiol—osteoporosis	0.000834	0.000834	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000831	0.000831	CcSEcCtD
Milnacipran—Urticaria—Zoledronate—osteoporosis	0.000827	0.000827	CcSEcCtD
Milnacipran—Abdominal pain—Zoledronate—osteoporosis	0.000823	0.000823	CcSEcCtD
Milnacipran—Body temperature increased—Zoledronate—osteoporosis	0.000823	0.000823	CcSEcCtD
Milnacipran—Diarrhoea—Risedronate—osteoporosis	0.00082	0.00082	CcSEcCtD
Milnacipran—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00082	0.00082	CcSEcCtD
Milnacipran—Dry mouth—Estradiol—osteoporosis	0.000818	0.000818	CcSEcCtD
Milnacipran—Asthenia—Pamidronate—osteoporosis	0.000818	0.000818	CcSEcCtD
Milnacipran—Dizziness—Ethinyl Estradiol—osteoporosis	0.000813	0.000813	CcSEcCtD
Milnacipran—Pruritus—Pamidronate—osteoporosis	0.000806	0.000806	CcSEcCtD
Milnacipran—Infection—Estradiol—osteoporosis	0.000797	0.000797	CcSEcCtD
Milnacipran—Urticaria—Conjugated Estrogens—osteoporosis	0.000796	0.000796	CcSEcCtD
Milnacipran—Dizziness—Risedronate—osteoporosis	0.000793	0.000793	CcSEcCtD
Milnacipran—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000792	0.000792	CcSEcCtD
Milnacipran—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000792	0.000792	CcSEcCtD
Milnacipran—Shock—Estradiol—osteoporosis	0.000789	0.000789	CcSEcCtD
Milnacipran—Nervous system disorder—Estradiol—osteoporosis	0.000787	0.000787	CcSEcCtD
Milnacipran—Tachycardia—Estradiol—osteoporosis	0.000783	0.000783	CcSEcCtD
Milnacipran—Vomiting—Ethinyl Estradiol—osteoporosis	0.000782	0.000782	CcSEcCtD
Milnacipran—Diarrhoea—Pamidronate—osteoporosis	0.00078	0.00078	CcSEcCtD
Milnacipran—Skin disorder—Estradiol—osteoporosis	0.000779	0.000779	CcSEcCtD
Milnacipran—Hyperhidrosis—Estradiol—osteoporosis	0.000775	0.000775	CcSEcCtD
Milnacipran—Rash—Ethinyl Estradiol—osteoporosis	0.000775	0.000775	CcSEcCtD
Milnacipran—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000775	0.000775	CcSEcCtD
Milnacipran—Headache—Ethinyl Estradiol—osteoporosis	0.00077	0.00077	CcSEcCtD
Milnacipran—Hypersensitivity—Zoledronate—osteoporosis	0.000767	0.000767	CcSEcCtD
Milnacipran—Vomiting—Risedronate—osteoporosis	0.000762	0.000762	CcSEcCtD
Milnacipran—Rash—Risedronate—osteoporosis	0.000756	0.000756	CcSEcCtD
Milnacipran—Dermatitis—Risedronate—osteoporosis	0.000755	0.000755	CcSEcCtD
Milnacipran—Dizziness—Pamidronate—osteoporosis	0.000754	0.000754	CcSEcCtD
Milnacipran—Headache—Risedronate—osteoporosis	0.000751	0.000751	CcSEcCtD
Milnacipran—Asthenia—Zoledronate—osteoporosis	0.000747	0.000747	CcSEcCtD
Milnacipran—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000738	0.000738	CcSEcCtD
Milnacipran—Pruritus—Zoledronate—osteoporosis	0.000736	0.000736	CcSEcCtD
Milnacipran—Nausea—Ethinyl Estradiol—osteoporosis	0.00073	0.00073	CcSEcCtD
Milnacipran—Insomnia—Estradiol—osteoporosis	0.000726	0.000726	CcSEcCtD
Milnacipran—Vomiting—Pamidronate—osteoporosis	0.000725	0.000725	CcSEcCtD
Milnacipran—Paraesthesia—Estradiol—osteoporosis	0.00072	0.00072	CcSEcCtD
Milnacipran—Asthenia—Conjugated Estrogens—osteoporosis	0.000719	0.000719	CcSEcCtD
Milnacipran—Rash—Pamidronate—osteoporosis	0.000719	0.000719	CcSEcCtD
Milnacipran—Dermatitis—Pamidronate—osteoporosis	0.000718	0.000718	CcSEcCtD
Milnacipran—Dyspnoea—Estradiol—osteoporosis	0.000715	0.000715	CcSEcCtD
Milnacipran—Headache—Pamidronate—osteoporosis	0.000714	0.000714	CcSEcCtD
Milnacipran—Somnolence—Estradiol—osteoporosis	0.000713	0.000713	CcSEcCtD
Milnacipran—Diarrhoea—Zoledronate—osteoporosis	0.000712	0.000712	CcSEcCtD
Milnacipran—Nausea—Risedronate—osteoporosis	0.000712	0.000712	CcSEcCtD
Milnacipran—Pruritus—Conjugated Estrogens—osteoporosis	0.000709	0.000709	CcSEcCtD
Milnacipran—Dyspepsia—Estradiol—osteoporosis	0.000706	0.000706	CcSEcCtD
Milnacipran—Decreased appetite—Estradiol—osteoporosis	0.000697	0.000697	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Estradiol—osteoporosis	0.000693	0.000693	CcSEcCtD
Milnacipran—Fatigue—Estradiol—osteoporosis	0.000692	0.000692	CcSEcCtD
Milnacipran—Dizziness—Zoledronate—osteoporosis	0.000688	0.000688	CcSEcCtD
Milnacipran—Constipation—Estradiol—osteoporosis	0.000686	0.000686	CcSEcCtD
Milnacipran—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000686	0.000686	CcSEcCtD
Milnacipran—Nausea—Pamidronate—osteoporosis	0.000677	0.000677	CcSEcCtD
Milnacipran—Dizziness—Conjugated Estrogens—osteoporosis	0.000663	0.000663	CcSEcCtD
Milnacipran—Vomiting—Zoledronate—osteoporosis	0.000662	0.000662	CcSEcCtD
Milnacipran—Rash—Zoledronate—osteoporosis	0.000656	0.000656	CcSEcCtD
Milnacipran—Gastrointestinal pain—Estradiol—osteoporosis	0.000656	0.000656	CcSEcCtD
Milnacipran—Dermatitis—Zoledronate—osteoporosis	0.000656	0.000656	CcSEcCtD
Milnacipran—Headache—Zoledronate—osteoporosis	0.000652	0.000652	CcSEcCtD
Milnacipran—Vomiting—Conjugated Estrogens—osteoporosis	0.000637	0.000637	CcSEcCtD
Milnacipran—Urticaria—Estradiol—osteoporosis	0.000637	0.000637	CcSEcCtD
Milnacipran—Abdominal pain—Estradiol—osteoporosis	0.000634	0.000634	CcSEcCtD
Milnacipran—Body temperature increased—Estradiol—osteoporosis	0.000634	0.000634	CcSEcCtD
Milnacipran—Rash—Conjugated Estrogens—osteoporosis	0.000632	0.000632	CcSEcCtD
Milnacipran—Dermatitis—Conjugated Estrogens—osteoporosis	0.000631	0.000631	CcSEcCtD
Milnacipran—Headache—Conjugated Estrogens—osteoporosis	0.000628	0.000628	CcSEcCtD
Milnacipran—Nausea—Zoledronate—osteoporosis	0.000618	0.000618	CcSEcCtD
Milnacipran—Nausea—Conjugated Estrogens—osteoporosis	0.000595	0.000595	CcSEcCtD
Milnacipran—Hypersensitivity—Estradiol—osteoporosis	0.000591	0.000591	CcSEcCtD
Milnacipran—Asthenia—Estradiol—osteoporosis	0.000576	0.000576	CcSEcCtD
Milnacipran—Pruritus—Estradiol—osteoporosis	0.000568	0.000568	CcSEcCtD
Milnacipran—Diarrhoea—Estradiol—osteoporosis	0.000549	0.000549	CcSEcCtD
Milnacipran—Dizziness—Estradiol—osteoporosis	0.00053	0.00053	CcSEcCtD
Milnacipran—Vomiting—Estradiol—osteoporosis	0.00051	0.00051	CcSEcCtD
Milnacipran—Rash—Estradiol—osteoporosis	0.000506	0.000506	CcSEcCtD
Milnacipran—Dermatitis—Estradiol—osteoporosis	0.000505	0.000505	CcSEcCtD
Milnacipran—Headache—Estradiol—osteoporosis	0.000503	0.000503	CcSEcCtD
Milnacipran—Nausea—Estradiol—osteoporosis	0.000476	0.000476	CcSEcCtD
